APVO Message Board Post 10602882 | Aptevo Therapeutics Inc.
home / stock / apvo / apvo message board
Faivre
(investorshangout)
Posted on: May/11/2020 21:16:16
Source: investorshangout
https://investorshangout.com/post/view?id=5764278
znewcar1: APVO 21% v1,23M c7.65 f3,2M H9.15 S7.45
News, Short Squeeze, Breakout and More Instantly...
-
SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that the Comp...
-
Lecture to focus on engineering strategies applied to design safe and efficacious bispecific drug candidates, utilizing our proprietary platform technologies SEATTLE, WA / ACCESSWIRE / May 14, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on ...
-
Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after entering the ALG.APV-527 Phase 1 trial with progressive disease and transitioning to higher dose with potential for greater clinical benefit, experienced no new a...